-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, Dow released its financial report for the fourth quarter of 2020, saying that as the economy continues to recover, Dow has achieved double growth in sales and profits, and most of its businesses have reached the level before the epidemic
.
In the fourth quarter, Dow's net sales were $10.
7 billion, up 5 percent from the same period last year, primarily due to higher local prices, currency exchange rates, and higher volumes
.
In the fourth quarter, Dow's net sales were $10.
Jim Fitterling, chairman and chief executive officer of Dow, said: "Dow's consumer-focused product portfolio and continued focus on capturing customer needs have resulted in higher sales in every regional market and every business segment.
Fitterling is confident in 2021 and beyond
.
As the market recovers further, Dow expects margins to improve as differentiated solutions across the company's product portfolio have seen increased demand
.
In the longer term, Dow expects to continue to create extraordinary value by enhancing innovation capabilities, improving operational efficiency, creating a leading environment, and improving social governance capabilities to further differentiate itself from the industry
.
